Amyloid related cerebral microbleed and plasma Aβ40 are associated with cognitive decline in Parkinson’s disease
Abstract Cerebral microbleeds (MBs) have been found in patients with cognitive decline. We aimed to examine whether MBs are associated with motor or cognitive decline in patients with Parkinson’s disease (PD). We enrolled 135 PD patients and 34 healthy controls. All participants underwent brain MRI...
Main Authors: | Hsin-Hsi Tsai, Li-Kai Tsai, Yen-Ling Lo, Chin-Hsien Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2021-03-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-021-86617-0 |
Similar Items
-
Differences in lobar microbleed topography in cerebral amyloid angiopathy and hypertensive arteriopathy
by: Pin-Yan Kuo, et al.
Published: (2024-02-01) -
Relation of plasma β‐amyloid, clusterin, and tau with cerebral microbleeds: Framingham Heart Study
by: José Rafael Romero, et al.
Published: (2020-07-01) -
Cerebral amyloid deposition predicts long‐term cognitive decline in hemorrhagic small vessel disease
by: Ya‐Chin Tsai, et al.
Published: (2023-10-01) -
Presence of cerebral microbleeds is associated with cognitive decline in acromegaly
by: Zhengxing Xie, et al.
Published: (2022-11-01) -
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
by: Noelia Fandos, et al.
Published: (2017-01-01)